Статья

Prevention and control of non-communicable diseases in the COVID-19 response

H. Kluge, K. Wickramasinghe, H. Rippin, R. Mendes, D. Peters, A. Kontsevaya, J. Breda,
2021

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • H. Kluge
    WHO Regional Office for Europe, Copenhagen, Denmark
  • K. Wickramasinghe
    WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow, 125009, Russian Federation
  • H. Rippin
    EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal
  • R. Mendes
    Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
  • D. Peters
    National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russian Federation
  • A. Kontsevaya
  • J. Breda
Название журнала
  • The Lancet
Том
  • 395
Выпуск
  • 10238
Страницы
  • 1678-1680
Ключевые слова
  • body mass; cause of death; chronic obstructive lung disease; comorbidity; coronavirus disease 2019; disease severity; health behavior; health care system; high risk population; human; hypertension; ischemic heart disease; isolation; malignant neoplasm; morbidity; mortality; non communicable disease; non insulin dependent diabetes mellitus; Note; obesity; pandemic; prevention and control; priority journal; public health service; quarantine; risk factor; Betacoronavirus; Coronavirus infection; Europe; non communicable disease; pandemic; virus pneumonia; Betacoronavirus; Comorbidity; Coronavirus Infections; Europe; Humans; Noncommunicable Diseases; Pandemics; Pneumonia, Viral
Издатель
  • Lancet Publishing Group
Тип документа
  • Note
Источник
  • scopus